不同临床与遗传背景下听神经病患者的畸变产物耳声发射恶化情况
该研究评估了31例听神经病患者的畸变产物耳声发射(DPOAE)时间进程,并分析其与遗传及临床背景(包括助听器使用)的关联。
要点
- 听神经病患者DPOAE可进行性下降或消失,儿童组约70%、成人组约80%出现恶化。
- 多数使用助听器的听神经病患者在助听器使用后DPOAE恶化,少数在使用前已恶化。
核心结论
- 儿童听神经病患者约70%、成人约80%出现DPOAE下降或消失。
- 成人组DPOAE很少完全消失,与遗传病因无关。
研究设计与样本
- 研究纳入31例听神经病患者,其中儿童组22例(诊断时<10岁),成人组9例(≥18岁)。
- 所有患者至少进行两次DPOAE测量,并检测GJB2、OTOF、线粒体m.1555A>G和m.3243A>G突变,部分病例检测CDH23和OPA1。
主要发现
- 儿童组:12耳(27%)DPOAE无变化,20耳(46%)下降,12耳(27%)消失;1耳(2%)在0岁消失,4耳(9%)在1岁消失。
- 成人组:4耳(22%)无变化,13耳(72%)下降,1耳(6%)消失。
- 儿童组OTOF突变患者DPOAE时间进程分为早期损失和无变化两类。
- 多数使用助听器的听神经病患者在开始使用后DPOAE恶化,少数在使用前已恶化。
- 成人组4耳OPA1突变和4耳OTOF突变均未出现DPOAE消失。
临床怎么用
- 听神经病患者应定期监测DPOAE,尤其儿童患者,以评估病情进展。
- 对使用助听器的听神经病患者需关注DPOAE变化,警惕听力恶化。
- 遗传检测有助于预测儿童听神经病DPOAE的转归。
局限性
- 样本量较小,尤其成人组仅9例。
- 部分病例病因未明,可能影响遗传因素分析。
- 回顾性设计,DPOAE测量间隔和随访时间未标准化。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Auditory neuropathy (AN) is a clinical disorder characterized by the absence of auditory brainstem response and presence of otoacoustic emissions. A gradual loss of otoacoustic emissions has been reported for some cases of AN. Such cases could be diagnosed as cochlear hearing loss and lead to misunderstanding of the pathology when patients first visit clinics after the loss of otoacoustic emissions. The purpose of this study was to investigate the time course of changes in distortion product otoacoustic emissions (DPOAEs) in association with patients' genetic and clinical backgrounds, including the use of hearing aids. DESIGN: DPOAE measurements from 31 patients with AN were assessed. Genetic analyses for GJB2, OTOF, and mitochondrial m.1555A> G and m.3243A> G mutations were conducted for all cases, and the analyses for CDH23 and OPA1 were conducted for the selected cases. Patients who were younger than 10 years of age at the time of AN diagnosis were designated as the pediatric AN group (22 cases), and those who were 18 years of age or older were designated as the adult AN group (9 cases). DPOAE was measured at least twice in all patients. The response rate for DPOAEs was defined and analyzed. RESULTS: The pediatric AN group comprised 10 patients with OTOF mutations, 1 with GJB2 mutations, 1 with OPA1 mutation, and 10 with indefinite causes. Twelve ears (27%) showed no change in DPOAE, 20 ears (46%) showed a decrease in DPOAE, and 12 ears (27%) lost DPOAE. Loss of DPOAE occurred in one ear (2%) at 0 years of age and four ears (9%) at 1 year of age. The time courses of DPOAEs in patients with OTOF mutations were divided into those with early loss and those with no change, indicating that the mechanism for deterioration of DPOAEs includes not only the OTOF mutations but also other common modifier factors. Most, but not all, AN patients who used hearing aids showed deterioration of DPOAEs after the start of using hearing aids. A few AN patients also showed deterioration of DPOAEs before using hearing aids. The adult AN group comprised 2 patients with OPA1 mutations, 2 with OTOF mutations, and 5 with indefinite causes. Four ears (22%) showed no change in DPOAE, 13 ears (72%) showed a decrease, and one ear (6%) showed a loss of DPOAE. Although the ratio of DPOAE decrease was higher in the adult AN group than in the pediatric AN group, the ratio of DPOAE loss was lower in the adult AN group. DPOAE was not lost in all four ears with OPA1 mutations and in all four ears with OTOF mutations in the adult group. CONCLUSIONS: DPOAE was decreased or lost in approximately 70% of pediatric and about 80% of adult AN patients. Eleven percent of pediatric AN patients lost DPOAEs by 1 year of age. Genetic factors were thought to have influenced the time course of DPOAEs in the pediatric AN group. In most adult AN patients, DPOAE was rarely lost regardless of the genetic cause.
引用
- Kitao K, Mutai H, Namba K, et al. Deterioration in Distortion Product Otoacoustic Emissions in Auditory Neuropathy Patients With Distinct Clinical and Genetic Backgrounds. Ear Hear. 2019. PMID: 29688962. doi:10.1097/AUD.0000000000000586
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。